Kinnate Biopharma Inc. is a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. The Company utilizes its deep specialization in structure-based drug discovery, translational research and patient-driven precision medicine, which is collectively referred as Kinnate Discovery Engine, to develop its targeted therapies. The Company’s advanced product candidate is KIN002787...